Skip to content

Effects of dexmedetomidine combined with transcutanclus electrical acupoint stimulation on postoperative sleep quality in gynecological laparoscopic surgery patients

Effects of dexmedetomidine combined with transcutanclus electrical acupoint stimulation on postoperative sleep quality in gynecological laparoscopic surgery patients

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071169
Enrollment
Unknown
Registered
2023-05-06
Start date
2023-05-08
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative sleep disturbance

Interventions

B Group:DEX+ Pseudo TEAS
C Group:TEAS + NS
D Group:Pseudo TEAS + NS
A group:Dexmedetomidine (DEX) and transcutanclus electrical acupoint stimulation (TEAS)

Sponsors

the First People's Hospital of Changde
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Voluntarily participate in this study, have full capacity for civil conduct, and sign informed consent. (2) Patients undergoing elective gynecological laparoscopic surgery , aged 18 to 65 years, BMI of 18.5 to 30 kg/m2, ASA grade I to ?, expected operation duration of more than 1 hour. (3) The patient did not participate in other drug clinical trials nearly 3 months before enrollment.

Exclusion criteria

Exclusion criteria: (1) Refuse to participate in the study; (2) preoperative sleep disturbance, PSQI=7 points; (3) Both cardiac pacemaker implantation; Taking anticoagulant after the operation of large heart vessels; (4) suffering from other endocrine and metabolic diseases; (5) A history of serious chronic diseases of the heart, brain, lung, liver, kidney, etc.; (6) Local skin allergy, damage or infection at the acupoint selection site; Suffering from a mental disorder, depression or neurological disease; (7) Taking drugs related to sleep before surgery; (8) Difficulty in communication; Unable to cooperate with the completion of relevant scale measurement; Severe hearing or visual impairment, unable to communicate effectively; (9) Pathological sinus syndrome, severe sinus bradycardia (<50/min), or secondary or higher atrioventricular block without pacemaker; (10) Allergies to opioid analgesics or DEX.

Design outcomes

Primary

MeasureTime frame
ncidence of postoperative sleep disturbance;

Secondary

MeasureTime frame
SMH scores;NRS pain scores;PSQI score;SMH score;

Countries

China

Contacts

Public ContactLiu Hongbo

the First People's Hospital of Changde

lhb963963@163.com+86 18229631011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026